CDT Equity CDT
NASDAQ CDT
$2.86 -0.04 (-1.38%)
At close: Aug 21, 2026 · 4:00 PM EDT

CDT Equity (CDT) Total Non-Current Liabilities (2022 - 2026)

CDT Equity's (CDT) quarterly Total Non-Current Liabilities came in at $20.9 million in Q1 2026, up 719.82% YoY from $2.5 million in Q1 2025, and up 71.57% on a QoQ basis from $12.2 million in Q4 2025.

CDT Equity (CDT) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends

CDT Equity (CDT) has 5 years of Total Non-Current Liabilities data on file, last reported at $20.9 million in Q1 2026.

  • Quarterly Total Non-Current Liabilities rose 719.82% year-over-year to $20.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.9 million (up 719.82% YoY) and the FY2025 annual result came in at $12.2 million, up 12.09% from the prior year.
  • Total Non-Current Liabilities grew to $20.9 million in Q1 2026, from $12.2 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $20.9 million in Q1 2026 to a low of -$3.4 million in Q1 2025.
  • A 5-year average of $8.8 million and a median of $8.3 million in 2024 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2025 — Total Non-Current Liabilities tumbled 142.52% — and 2026, when it surged 719.82%.
  • Tracing CDT's Total Non-Current Liabilities over 5 years: stood at $6.8 million in 2022, then increased by 10.19% to $7.5 million in 2023, then jumped by 43.89% to $10.8 million in 2024, then grew by 12.09% to $12.2 million in 2025, then jumped by 71.57% to $20.9 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $20.9 million (Q1 2026), $12.2 million (Q4 2025), and $4.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 5.92 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 7.74 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 40.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 3.92 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.88 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 4.20 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 724.15 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 1.17 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 9.32 Bn
10 CDT Equity 1.55 Mn 1.55 Mn - 195,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 195,000.00
Mar 31, 2026 20.86 Mn
Dec 31, 2025 12.16 Mn
Sep 30, 2025 4.27 Mn
Jun 30, 2025 4.46 Mn
Mar 31, 2025 -3.37 Mn
Dec 31, 2024 10.85 Mn
Sep 30, 2024 12.09 Mn
Jun 30, 2024 8.74 Mn
Mar 31, 2024 7.92 Mn
Dec 31, 2023 7.54 Mn
Sep 30, 2023 13.01 Mn
Dec 31, 2022 6.84 Mn